Bone Support

Share Price

  • Contact Us
Follow
  • US site
    • Global English Site
    • US site
    • Global Swedish Site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Corporate Social Responsibility
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT® BONE VOID FILLER
    • CERAMENT® BEAD TRAY
    • Bone Marrow Harvest Needle
    • Purchasing products
  • Innovation
    • Pipeline
    • CERTiFy Clinical Trial
    • FORTIFY Clinical Trial
  • Medical Professionals
    • TRAUMA: WHY USE CERAMENT®
    • BENIGN BONE TUMORS: WHY USE CERAMENT®
    • REVISION ARTHROPLASTY: WHY USE CERAMENT
    • FOOT AND ANKLE: WHY USE CERAMENT
  • Investors
    • Financials
    • Financial Reports
    • Presentations
    • The Share
    • Shareholders
    • Analyst Coverage
    • Corporate Governance
    • Calendar
    • Q&A
    • Definitions
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Media
    • Press Releases
    • Publications and Resources
    • Multimedia
    • Events
  • Contact Us
  • Global English Site
  • US site
  • Global Swedish Site
  • Financials
  • Financial Reports
  • Presentations
  • The Share
  • Shareholders
  • Analyst Coverage
  • Corporate Governance
  • Calendar
  • Q&A
  • Definitions

Financial Reports 2018

BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017.

PDF Icon

Annual Report 2018

17/04/2019

PDF Icon

Full Year Report 2018

27/02/2019

Net sales amounted to SEK 96.6 million (129.3), a decrease of 25%. Gross margin of 84% (87). Operating loss of SEK -174.4 million (-99.3).
PDF Icon

Interim Report, Q3, July - September2018

07/11/2018

Net Sales amounted to SEK 73.5 million (102.3), a decrease of 28%. Gross margin of 85.9% (87.9). Operating loss of SEK -128.1 million (-65.9).
PDF Icon

Interim Report, Q2, April - June 2018

26/07/2018

Net sales amounted to SEK 28.2 million (37.1), a decrease of 24%. Gross margin 87.4 % (87.2%). Operating loss of SEK -37.8 million (-18.4).
PDF Icon

Interim Report, Q1, January - March 2018

14/05/2018

Net sales amounted to SEK 31.1 million (32.5), an decrease of 4%. Gross margin 82.1 % (88.8%). Operating loss of SEK -33.1 million (-27.4).

©BONESUPPORT AB 2021. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy